APA

Michaelis K. A., Norgard M. A., Zhu X., Levasseur P. R., Sivagnanam S., Liudahl S. M., Burfeind K. G., Olson B., Pelz K. R., Ramos D. M. A., Maurer H. C., Olive K. P., Coussens L. M., Morgan T. K. & Marks D. L. (2019). Publisher Correction: The TLR7/8 agonist R848 remodels tumor and host responses to promote survival in pancreatic cancer. : Nature communications.

Chicago

Michaelis Katherine A, Norgard Mason A, Zhu Xinxia, Levasseur Peter R, Sivagnanam Shamilene, Liudahl Shannon M, Burfeind Kevin G, Olson Brennan, Pelz Katherine R, Ramos Diana M Angeles, Maurer H Carlo, Olive Kenneth P, Coussens Lisa M, Morgan Terry K and Marks Daniel L. 2019. Publisher Correction: The TLR7/8 agonist R848 remodels tumor and host responses to promote survival in pancreatic cancer. : Nature communications.

Harvard

Michaelis K. A., Norgard M. A., Zhu X., Levasseur P. R., Sivagnanam S., Liudahl S. M., Burfeind K. G., Olson B., Pelz K. R., Ramos D. M. A., Maurer H. C., Olive K. P., Coussens L. M., Morgan T. K. and Marks D. L. (2019). Publisher Correction: The TLR7/8 agonist R848 remodels tumor and host responses to promote survival in pancreatic cancer. : Nature communications.

MLA

Michaelis Katherine A, Norgard Mason A, Zhu Xinxia, Levasseur Peter R, Sivagnanam Shamilene, Liudahl Shannon M, Burfeind Kevin G, Olson Brennan, Pelz Katherine R, Ramos Diana M Angeles, Maurer H Carlo, Olive Kenneth P, Coussens Lisa M, Morgan Terry K and Marks Daniel L. Publisher Correction: The TLR7/8 agonist R848 remodels tumor and host responses to promote survival in pancreatic cancer. : Nature communications. 2019.